Rakuten Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.69M Sell
1,832
-9
-0.5% -$9.12K 0.7% 35
2025
Q4
$1.98M Sell
1,841
-3,426
-65% -$3.28M 0.64% 34
2025
Q3
$4.02M Buy
5,267
+1,215
+30% +$904K 1.48% 13
2025
Q2
$3.16M Buy
4,052
+498
+14% +$387K 1.24% 16
2025
Q1
$2.94M Sell
3,554
-1,758
-33% -$1.46M 1.48% 15
2024
Q4
$4.1M Sell
5,312
-1,336
-20% -$1.11M 1.61% 8
2024
Q3
$5.89M Buy
6,648
+3,189
+92% +$2.87M 2.56% 6
2024
Q2
$3.13M Buy
3,459
+503
+17% +$402K 1.34% 11
2024
Q1
$2.3M Buy
2,956
+1,542
+109% +$1.1M 1.01% 19
2023
Q4
$824K Buy
+1,414
New +$825K 0.65% 29

Other funds holding LLY

Rakuten Securities's LLY Position: Q1 2026 in Review

Rakuten Securities reduced its Eli Lilly (LLY) stake by 0.49% in Q1 2026, selling an estimated $9.12K and leaving 1,832 shares worth $1.69M. The position accounts for 0.7% of the portfolio, ranked #35.

Rakuten Securities first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $5.89M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Rakuten Securities held 1,832 shares of Eli Lilly worth $1.69M as of Q1 2026.
  • Rakuten Securities sold 9 Eli Lilly shares in Q1 2026, an estimated $9.12K.
  • Eli Lilly made up 0.7% of Rakuten Securities's portfolio in Q1 2026, its #35 holding.
  • Rakuten Securities first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Rakuten Securities's Eli Lilly position peaked at $5.89M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Rakuten Securities's 13F filing for Q1 2026, filed 1 May 2026.